{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:04:43Z","timestamp":1757779483469},"reference-count":14,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.vaccine.2015.08.003","type":"journal-article","created":{"date-parts":[[2015,8,10]],"date-time":"2015-08-10T23:50:43Z","timestamp":1439250643000},"page":"5135-5139","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hepatitis A virus antibodies in Australian blood donors: Implications for immunoglobulin sufficiency"],"prefix":"10.1016","volume":"33","author":[{"given":"Megan K.","family":"Young","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen M.","family":"Faddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Fryk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme R.","family":"Nimmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan W.","family":"Cripps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"28\u201329","key":"10.1016\/j.vaccine.2015.08.003_bib0075","first-page":"261","article-title":"WHO position paper on hepatitis A vaccines \u2013 June 2012","volume":"87","author":"World Health Organisation","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"issue":"January (Suppl.)","key":"10.1016\/j.vaccine.2015.08.003_bib0080","article-title":"Vaccine preventable disease in Australia, 2005 to 2007","volume":"34","author":"NCIRS","year":"2010","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2015.08.003_bib0085","series-title":"The Australian immunisation handbook","author":"Australian Technical Advisory Group on Immunisation","year":"2013"},{"issue":"7","key":"10.1016\/j.vaccine.2015.08.003_bib0090","doi-asserted-by":"crossref","first-page":"338","DOI":"10.5694\/j.1326-5377.2001.tb143309.x","article-title":"Hepatitis A epidemiology in Australia: national seroprevalence and notifications","volume":"174","author":"Amin","year":"2001","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2015.08.003_bib0095","series-title":"The global prevalence of hepatitis A virus infection and susceptibility: a systematic review","author":"Jacobsen","year":"2009"},{"key":"10.1016\/j.vaccine.2015.08.003_bib0100","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1017\/S0950268804002857","article-title":"Declining hepatitis A seroprevalence: a global review and analysis","volume":"132","author":"Jacobsen","year":"2004","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2015.08.003_bib0105","series-title":"Hepatitis A: national guidelines for public health units","author":"CDNA","year":"2009"},{"key":"10.1016\/j.vaccine.2015.08.003_bib0110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jmv.1890400106","article-title":"Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization","volume":"40","author":"Zaaijer","year":"1993","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2015.08.003_bib0115","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1016\/j.vaccine.2012.07.058","article-title":"Changes in seroprevalence to hepatitis A in Victoria, Australia: a comparison of three time points","volume":"30","author":"Heywood","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.003_bib0120","doi-asserted-by":"crossref","DOI":"10.1007\/s10393-014-1005-0","article-title":"Seroprevalence of antibodies to ross river and barmah forest viruses: possible implications for blood transfusion safety after extreme weather events","author":"Faddy","year":"2014","journal-title":"EcoHealth"},{"issue":"3","key":"10.1016\/j.vaccine.2015.08.003_bib0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/sim.4780100317","article-title":"Confidence intervals for weighted sums of poisson parameters","volume":"10","author":"Dobson","year":"1991","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2015.08.003_bib0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2893.1997.00059.x","article-title":"Exposure to hepatitis A virus among blood donors, injecting drug users and prison entrants in Victoria","volume":"4","author":"Crofts","year":"1997","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.vaccine.2015.08.003_bib0135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/1471-2458-12-321","article-title":"A cross-sectional study of pre-travel health-seeking practices among travelers departing Sydney and Bangkok airports","volume":"12","author":"Heywood","year":"2012","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2015.08.003_bib0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1708-8305.2006.00088.x","article-title":"Pretravel advice and hepatitis A immunization among Australian travelers","volume":"14","author":"Zwar","year":"2007","journal-title":"J Travel Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15011111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15011111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T01:57:33Z","timestamp":1599443853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15011111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":14,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0264410X15011111"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.08.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis A virus antibodies in Australian blood donors: Implications for immunoglobulin sufficiency","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}